Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)

Name: Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-30

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23) (French, HTML) HTML
Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23) (English, HTML) HTML

Related open data

Health Canada